Ka-Yi Lau

Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells

Chun-Yu Liu, Ka-Yi Lau, Chia‐Chi Hsu et al. · PLoS ONE · 2017 · 64 citations · Full text

Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression

Chun-Yu Liu, Tzu‐Ting Huang, Yi‐Ting Chen et al. · EBioMedicine · 2019 · 52 citations · Full text

EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells

Chun‐Yu Liu, Tzu‐Ting Huang, Chun‐Teng Huang et al. · European Journal of Cancer · 2016 · 39 citations

Erlotinib Derivative Td52, Medicine, Receptor Tyrosine Kinase +8

The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells

Chun‐Yu Liu, Tzu‐Ting Huang, Pei‐Yi Chu et al. · Experimental & Molecular Medicine · 2017 · 39 citations · Full text

Breast Oncology, Apoptosis, Cell Death +18

Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells

Chun‐Yu Liu, Kuen‐Feng Chen, Tzu-I Chao et al. · Journal of Molecular Medicine · 2017 · 24 citations

P-stat3 Signaling, Sequential Combination, Medicine +8